GEHC GE HealthCare Technologies Inc.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at GE HealthCare (NASDAQ:GEHC) and the best and worst performers in the healthcare equipment and supplies industry.

GEHC's record backlog, strong orders and AI-enabled innovations offer growth potential, while inflation and China remain key risks.

Needham thinks the worst-case outcome for the MRI, CT, and ultrasound machine maker may already be fading.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in hospital imaging, including MRI, CT, and ultrasound machines, and the contrast agents required to interpret scans. Spun out of General Electric in early 2023, GE HealthCare traded near its 52-week low of $58.75 and 28% below its high of $89.77, at a closing price of $64.81 on September […]

Needham initiated coverage with a ‘Buy’ rating and $93 price target, putting GEHC among the stocks it expects to outperform.

Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls

GE HealthCare Technologies (GEHC) just launched CareIntellect for Operations, an AI SaaS tool that forecasts hospital capacity constraints up to 72 hours ahead and suggests actions, giving investors another data point on its software push. Despite the AI push, GE HealthCare Technologies shares have been under pressure, with the 30-day share price return down 13.38% and the year-to-date share price return down 21.75%, while the 1-year total shareholder return has declined 13.16% and the 3-year...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is reportedly discussing a possible $1 billion acquisition of Sofie Biosciences. Reuters reported the talks on September 13, citing the Financial Times, which attributed them to people familiar with the matter. Reuters could not independently verify the report, and no agreement was confirmed in its coverage. The strategic question starts […]

GEHC vs. SYK: Which Stock Is the Better Value Option?

GE HealthCare launches an AI-powered SaaS tool that predicts hospital capacity challenges up to 72 hours ahead and recommends actions to ease bottlenecks.

GE HealthCare has lagged behind the Nasdaq Composite over the past year, and analysts remain moderately bullish about the stock’s outlook.

GEHC moves StarGuide GX closer to the U.S. market with an FDA 510(k) submission, advancing its next-generation molecular imaging push.

GE Aerospace is buying Consolidate Precision Products for almost $12 billion. It’s a big deal for the jet engine maker.

GE HealthCare Technologies has slipped year to date, yet on broad valuation checks the stock still screens as relatively cheap compared with its fundamentals. Investors are weighing that disconnect against a steady stream of product developments in imaging and cardiology. Year to date, GE HealthCare Technologies is down 14.8%, which may make the current share price more interesting for value focused investors who already follow the company. Progress in advanced imaging such as the Photonova...

GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.

On August 31, GE HealthCare (NASDAQ:GEHC) announced that its Photonova Spectra photon-counting CT scanner had received CE Mark approval, opening the door to sales across Europe and other regions that recognize the certification. The clearance followed US FDA 510(k) clearance and Japanese regulatory approval in March 2026, meaning the machine cleared three major regulatory bodies […]

Photonova Spectra is designed to deliver ultra-high definition and on-demand spectral and spatial imaging.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

GEHC vs. HAE: Which Stock Is the Better Value Option?

GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.

GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

One trades at a massive valuation premium while burning cash; the other generates billions in free cash flow with established customers.

Honeywell Aerospace's first earnings report as a stand-alone company missed estimates and cut guidance, sending shares down 23%, though backlog growth and analyst targets suggest a supply, not demand, issue.

GE HealthCare Technologies (GEHC) has drawn fresh attention after announcing William K. Grogan as its incoming Chief Financial Officer, effective September 14, 2026, following his finance leadership roles at Xylem and IDEX. For investors watching GE HealthCare Technologies, the recent CFO news comes after a strong 30 day share price return of 22% and a 90 day share price return of 15.7%. However, the year to date share price return is down 10.76%, and the 1 year total shareholder return is...

GEHC's 11.1% order growth and record $23.9B backlog improve revenue visibility, but PCS execution and inflation remain key constraints.

GEHC's valuation discount and growth in imaging and diagnostics support the case, but PCS weakness, inflation and debt keep execution risks elevated.

GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support its growth outlook despite margin pressures.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Boot Barn, Five Below, The Ensign and GE HealthCare have been highlighted in this Screen of The Week article.

Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach.

William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.

Healthcare stocks were higher late Tuesday afternoon, with the NYSE Healthcare Index and the State S

Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 1.8% and the

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]

GE HealthCare Technologies stock has climbed 19.7% over the past month, yet its valuation checks still lean toward the shares looking cheap rather than stretched. The 19.7% gain over the past month points to a sharp reset in expectations that puts the current pricing under closer scrutiny for new buyers and existing holders. Recent expansion of ultrasound and breast imaging platforms can support expectations for future revenue, while execution risks around new product rollouts may affect how...

Earlier this month, GE HealthCare introduced the LOGIQ e Xi and LOGIQ e Si laptop ultrasound systems and launched the Invenia ABUS Prime and ABUS StreamVue breast imaging solutions, expanding its AI-enabled and cloud-connected ultrasound portfolio across multiple care settings. These product launches aim to standardize imaging workflows, support remote reading, and address dense-breast screening needs, potentially strengthening GE HealthCare’s position in high-value, technologically advanced...

GEHC vs. LMAT: Which Stock Is the Better Value Option?

GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

GE HealthCare has lagged the broader market despite strong earnings, while analysts remain moderately optimistic about its future prospects.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Record backlog and orders surge, but Patient Care Solutions struggles weigh on margins.

GE HealthCare posted strong Q2 results with record backlog and book-to-bill, while reviewing a possible sale of its underperforming Patient Care Solutions segment.

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5.8% year on year to $5.30 billion. Its non-GAAP profit of $1.13 per share was 9.1% above analysts’ consensus estimates.

Record backlog and orders surge, but Patient Care Solutions struggles weigh on margins.

GE HealthCare Technologies (GEHC) is back in focus after its second quarter report highlighted 11% order growth, a record US$23.9b backlog, and maintained full year guidance, despite persistent pressure in Patient Care Solutions. See our latest analysis for GE HealthCare Technologies. The Q2 update and PCS review arrived alongside a sharp shift in sentiment, with GE HealthCare Technologies posting a 1-day share price return of 12.15% and a 7-day share price return of 17.08%. However, the year...